GlassScriptPhysician profile
Michael S Huang
NPI 1659566628
$7,080.88
in general payments reported to CMS, 2019-2025
22 companies · $662 in 2025
The $662 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,359 · 2020: $262 · 2021: $1,786 · 2022: $717 · 2023: $1,909 · 2024: $386 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825 · Travel and Lodging: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,825.30 |
| Travel and Lodging | $1,131.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,864.77 | 2019-2025 | Impella |
| Abbott Laboratories | $1,915.42 | 2019-2025 | Optis, Thoratec Heartmate 3 Lvas Implant Kit, Esprit |
| Astrazeneca Pharmaceuticals LP | $294.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $279.97 | 2020-2023 | |
| Shockwave Medical, INC | $279.28 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Janssen Pharmaceuticals, INC | $218.07 | 2020-2023 | Xarelto |
| Amgen INC. | $214.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $205.59 | 2021-2023 | Verquvo |
| Edwards Lifesciences Corporation | $111.05 | 2019 | |
| Pfizer INC. | $109.12 | 2021-2023 | |
| Biotronik INC. | $104.79 | 2022 | |
| Medtronic, INC. | $92.33 | 2022-2024 | Onyx Frontier |
| Biosense Webster, INC. | $89.42 | 2023 | Qdot Micro Catheter |
| Boston Scientific Corporation | $66.87 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.73 | 2022-2023 | Jardiance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $39.70 | 2021-2023 | Zio Xt Patch |
| Zoll Circulation INC | $36.16 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.39 | 2021 | |
| Angiodynamics, INC. | $31.00 | 2025 | Angiovac |
| E.R. Squibb & Sons, L.L.C. | $28.56 | 2022-2024 | Camzyos |
| Esperion Therapeutics, INC. | $26.87 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.